Dose Escalation of Whole-Brain Radiotherapy for Brain Metastases From Melanoma

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 2, 2010, Pages 537-541

  Rades, Dirk ^a   Heisterkamp, Christine ^a   Huttenlocher, Stefan ^a   Bohlen, Guenther ^a   Dunst, Juergen ^a   Haatanen, Tiina ^b   Schild, Steven E ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

Brain metastases; Dose escalation; Melanoma; Treatment outcome

Indexed keywords

BRAIN METASTASIS; CLASS 1; DOSE ESCALATION; HYPOFRACTIONATION; MULTI VARIATE ANALYSIS; PERFORMANCE STATUS; POTENTIAL BENEFITS; PROGNOSTIC FACTORS; RANDOMIZED TRIAL; RECURSIVE PARTITIONING ANALYSIS; TREATMENT OUTCOMES; WHOLE BRAIN RADIOTHERAPY;

BRAIN; DECISION MAKING; DERMATOLOGY; MULTIVARIANT ANALYSIS; ONCOLOGY; RADIOTHERAPY; REGRESSION ANALYSIS;

PATHOLOGY;

ADULT; AGE; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; WHOLE BRAIN RADIOTHERAPY;

AGE FACTORS; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 77951847179     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.05.001     Document Type: Article

References (21)

1. Jemal A., Siegal R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Morris S.L., Low S.H., A'Hern R.P., et al. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer 91 (2004) 829-833
3. Harrison B.E., Johnson J.L., Clough R.W., et al. Selection of patients with melanoma brain metastases for aggressive treatment. Am J Clin Oncol 26 (2003) 354-357
4. Sampson J.H., Carter J.H., Friedman A.H., et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88 (1998) 11-20
5. Madajewicz S., Karakousis C., West C.R., et al. Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer 53 (1984) 2550-2552
6. Gupta G., Robertson A.G., and MacKie R.M. Cerebral metastases of cutaneous melanoma. Br J Cancer (1997) 256-259
7. Ziegler J.C., and Cooper J.S. Brain metastases from malignant melanoma: conventional vs. high-dose-per-fraction radiotherapy. Int J Radiat Oncol Biol Phys 12 (1986) 1839-1842
8. Ellerhorst J., Strom E., Nardone E., et al. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 49 (2001) 93-97
9. nd edition) (2007), Elsevier Churchill Livingstone, Philadelphia 865-877
10. Chang D.T., Amdur R.J., Morris C.G., et al. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys 66 (2006) 1051-1055
11. Fenig E., Eidelevich E., Njuguna E., et al. Role of radiation therapy in the management of cutaneous melanoma. Am J Clin Oncol 22 (1999) 184-186
12. Sause W.T., Cooper J.S., Rush S., et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20 (1991) 429-432
13. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 (1997) 745-751
14. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
15. Mori Y., Kondziolka D., Flickinger J.C., et al. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42 (1998) 581-589
16. Yu C., Chen J.C.T., Apuzzo M.L.J., et al. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 52 (2002) 1277-1287
17. Powell J.W., Chung C.T., Shah H.R., et al. Gamma knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. J Neurosurg 109 (2008) 122-128
18. Redmond A.J., DiLuna M.L., Herbert R., et al. Gamma knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival. J Neurosurg 109 (2008) 99-105
19. Atkins M.B., Sosman J.A., Agarwala S., et al. Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma. Cancer 113 (2008) 2139-2145
20. Joiner M.C., and Van der Kogel A.J. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel G.G. (Ed). Basic clinical radiobiology (1997), Oxford University Press, New York 106-112
21. Isokangas O.P., Muhonen T., Kajanti M., et al. Radiation therapy of intracraial malignant melanoma. Radiother Oncol 38 (1996) 139-144